Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-09

Clinical Trial Update: Vardenafil in Tinnitus [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of vardenafil for tinnitus, sponsored by Bayer, has completed. The study status is reported as completed in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vardenafil (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Tinnitus | Phase 2 | Status: COMPLETED